Good news from the HMR Foundation

Last week, with the support of the HMR Foundation, the Hôpital Maisonneuve-Rosemont (HMR) has taken one more step forward in the battle against cancer. The Honourable Kirsty Duncan, Canada’s Minister of Science, Mr. Gaétan Barrette, Quebec Minister of Health and Social Services, Montreal Mayor Denis Coderre and numerous other partners gathered at the HMR to mark the launch of the Centre for Commercialization of Cancer Immunotherapy (C3i).

Operating out of the HMR, this new centre will help refine innovative, non-toxic cancer treatments through immunotherapy. These revolutionary treatments harness the power of the immune system without using chemotherapy agents. They represent the future of medicine and they are being developed right here at the HMR!

The new Centre for Commercialization of Cancer Immunotherapy (C3i) will help propel Canada to the rank of world leader in the field of cancer immunotherapy. The new centre will operate out of the HMR Centre of Excellence for Cellular Therapy (CECT) that was made possible thanks to the nearly 9 million dollars in financial support provided by the HMR Foundation and its generous donors since 2011. Today, the CECT offers the greatest expertise in cellular therapy Canada-wide and it is one of the largest stem cell transplantation centres in the country.

Matthew Schreindorfer and Mai Duong, two patients who have benefited from immunotherapy treatments that are only offered at the HMR, were on site to share their gratitude and to celebrate the realization of this project that is such a beacon of hope for cancer sufferers and their loved ones.

In addition to the 15 million dollars granted by the Federal Government and the 2.5 million dollars provided by the provincial government, contributions totalling 35 million dollars from over 40 industrial partners or universities have led to the realization of this large-scale project. Learn how you can donate to the HMR Foundation

These topics may be of interest to you